Genomic epidemiology and evolutionary dynamics of the Omicron variant of SARS-CoV-2 during the fifth wave of COVID-19 in Pakistan.

Genomic epidemiology and evolutionary dynamics of the Omicron variant of SARS-CoV-2 during the fifth wave of COVID-19 in Pakistan.

Publication date: Aug 22, 2024

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed extraordinary challenges to global health systems and economies. The virus’s rapid evolution has resulted in several variants of concern (VOCs), including the highly transmissible Omicron variant, characterized by extensive mutations. In this study, we investigated the genetic diversity, population differentiation, and evolutionary dynamics of the Omicron VOC during the fifth wave of COVID-19 in Pakistan. A total of 954 Omicron genomes sequenced during the fifth wave of COVID-19 in Pakistan were analyzed. A Bayesian framework was employed for phylogenetic reconstructions, molecular dating, and population dynamics analysis. Using a population genomics approach, we analyzed Pakistani Omicron samples, revealing low within-population genetic diversity and significant structural variation in the spike (S) protein. Phylogenetic analysis showed that the Omicron variant in Pakistan originated from two distinct lineages, BA. 1 and BA. 2, which were introduced from South Africa, Thailand, Spain, and Belgium. Omicron-specific mutations, including those in the receptor-binding domain, were identified. The estimated molecular evolutionary rate was 2. 562E-3 mutations per site per year (95% HPD interval: 8. 8067E-4 to 4. 1462E-3). Bayesian skyline plot analysis indicated a significant population expansion at the end of 2021, coinciding with the global Omicron outbreak. Comparative analysis with other VOCs showed Omicron as a highly divergent, monophyletic group, suggesting a unique evolutionary pathway. This study provides a comprehensive overview of Omicron’s genetic diversity, genomic epidemiology, and evolutionary dynamics in Pakistan, emphasizing the need for global collaboration in monitoring variants and enhancing pandemic preparedness.

Open Access PDF

Concepts Keywords
1462e Bayes Theorem
Coronavirus COVID-19
Genetic COVID-19
Pandemic Evolution, Molecular
Spain Genetic Variation
Genome, Viral
genomic epidemiology
Humans
Mutation
Omicron
Pakistan
Phylogeny
SARS-CoV-2
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2
VOCs

Semantics

Type Source Name
disease MESH COVID-19
disease IDO protein
disease IDO site
disease MESH Infection
drug DRUGBANK Coenzyme M
disease IDO cell
pathway REACTOME Reproduction
disease MESH morbidity
disease IDO infectivity
disease MESH breakthrough infection
disease MESH reinfection
disease IDO history
disease IDO algorithm
disease MESH mutation rate
disease IDO country
drug DRUGBANK Amino acids
drug DRUGBANK Pentaerythritol tetranitrate
pathway REACTOME Immune System
drug DRUGBANK L-Leucine
drug DRUGBANK L-Phenylalanine
disease IDO host
drug DRUGBANK L-Lysine
drug DRUGBANK L-Arginine
disease IDO susceptibility
disease MESH long term infection
disease IDO process
drug DRUGBANK L-Aspartic Acid
drug DRUGBANK Serine
drug DRUGBANK Guanosine
disease MESH pneumonia

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *